Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Thoracic Cancer|February 5, 2020
Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor-related hematological adverse eventsJunling Zhuang, Jianhua Du, Xiaoxiao Guo, et al.
The Oncologist|May 20, 2026
Efficacy and Safety of Tocilizumab for Neoplastic Fever in Patients with Advanced Solid Tumors: A Multicenter Retrospective StudyYu Yan, Xiaoyan Liu, Yang Du, et al.
Thoracic Cancer|June 17, 2025
Safety and Efficacy of the First Subcutaneous ICI, Envafolimab, in the Treatment of Advanced Lung Cancer Patients: A Real-World StudyZixuan Dou, Li Wang, Meng Rui, et al.
Translational Lung Cancer Research|June 15, 2026
Elevated baseline C-reactive protein predicts poorer survival in lung cancer: a 22-year retrospective cohort studyXiaomin Wei, Xiaoyan Liu, Mei Li, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|October 26, 2019
[Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-related Hematological Adverse Events]Junling Zhuang, Jingting Zhao, Xiaoxiao Guo, et al.
Thoracic Cancer|February 5, 2020
Clinical diagnosis and treatment recommendations for ocular toxicities of targeted therapy and immune checkpoint inhibitor therapyXiaowei Liu, Zheng Wang, Chan Zhao, et al.
International Immunopharmacology|January 12, 2025
Peripheral blood PD-1+ T lymphocytes as biomarkers in liquid biopsies for solid tumors: Clinical significance and prognostic applicationsMingjian Piao, Nan Zhang, Jiongyuan Li, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|October 26, 2019
[Clinical Diagnosis and Treatment Recommendations for Ocular Toxicities of Target Therapy and Immune Checkpoint Inhibitor Therapy]Xiaowei Liu, Zheng Wang, Chan Zhao, et al.
Thoracic Cancer|January 3, 2023
The development of a tumor-associated autoantibodies panel to predict clinical outcomes for immune checkpoint inhibitor-based treatment in patients with advanced non-small-cell lung cancerJing Zhao, Yang Wu, Yuan Yue, et al.
Translational Lung Cancer Research|January 9, 2026
Real-world outcomes of first-line immunotherapy and subsequent systemic therapies in pleural mesothelioma: a multicenter study in ChinaBinhe Tian, Boyu Sun, Zixiang Zhou, et al.
Pageof 12